IMS Reports AbbVie (ABBV) Viekira Pak Week 1 Scripts (GILD)
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/27/2026
- Nvidia's revenue forecast lifts Wall Street; investors eye the Fed's Warsh
- Nvidia forecasts 70% sales growth next year, signals AI spending boom has years left to run
- Oil jumps over $2 after Trump rejects return to Iran ceasefire deal terms
- Could SpaceX's orbital compute avoid the political headwinds facing data centers?
- Could Meta's teen settlement be less painful than feared? Citi weighs in
- Nutanix (NTNX) Tops Q4 EPS by 11c, Beats in Revenue; Offers Q1 Revenue Guidance
- Boston Scientific discloses cybersecurity incident causing global disruption
- Crude Inventory Rose 0.1 Million Barrels Last Week - EIA
- First Financial to acquire Hickory Point Bank in $111.3M deal
- Revolution Medicines prices RASONQUE at $39,800 per month
AbbVie (ABBV), BioPharma's on Watch; Gilead's Havroni Receives Preferred Status at CVS (AMGN)
January 5, 2015 11:53 AM ESTAbbVie (NYSE: ABBV) shares are active following news that Gilead's (Nasdaq: GILD) Havroni received preferred formulary status by CVS Health.
Other biopharma's on watch: Amgen (NASDAQ: AMGN), Biogen Idec (NASDAQ: BIIB), BioMarin Pharma (NASDAQ: BMRN), Celgene (NASDAQ: CELG),, Incyte (NASDAQ: INCY), and Pharmacyclics (NASDAQ: PCYC).
... MoreGilead Sciences (GILD) PT Trimmed to $146 at Nomura; 'Buy' Maintained
January 5, 2015 11:02 AM ESTNomura Securities analyst M. Ian Somaiya reiterated a Buy rating but lowered his price target on Gilead Sciences (NASDAQ: GILD) to $146.00 (from $152.00).
The lowered price target accounts for more aggressive discounting from AbbVie and Express Scripts agreement.
For an analyst ratings... More
RBC Outlines What to Expect Ahead of Initial AbbVie (ABBV) Viekira Pak Scripts (GILD)
December 31, 2014 5:57 AM ESTRBC Capital offered commentary on Gilead Sciences (Nasdaq: GILD) ahead of AbbVie (NYSE: ABBV) prescription data, which could be made available this Friday (January 2nd).
Analyst Michael Yee sees initial Viekira Pak scripts being small given the holiday week, but expects a gradual pickup... More
